Pharmafile Logo

The Trust Test

- PMLiVE

Horizon sunny as thyroid eye disease drug hits the mark

New treatment helps lessen eye bulging

- PMLiVE

NHS England’s medicines chief: stop ‘salami slicing’ and get faster market access

Pressure will be maintained on costs, despite VPAS price cap deal

Bristol-Myers Squibb (BMS) building

Reluctant shareholders threaten $74bn BMS merger with Celgene

Shareholders claim merger undervalues BMS but analysts convinced the deal will close

Storm Chasers

The way people respond to tornado warnings may have public health implications

- PMLiVE

UK launches National Genomic Healthcare strategy

New initiative unveiled to coincide with Rare Disease Day

- PMLiVE

Rare Diseases Day

More than other conditions, rare diseases require a human touch, but technology can provide a vital helping hand

- PMLiVE

UCB looks to pipeline with five years left for twin blockbusters

CEO outlines pipeline promise, won't write off post-Brexit UK

- PMLiVE

Sage raises $575m ahead of FDA review date for Zulresso

Company should get verdict by 19 March

- PMLiVE

EMA could follow FDA’s Xeljanz blood clot warning

European agency in step with FDA after safety doubts

Bluedog Launch Celebrations

Teams from all companies within the Lucid Group and Bluedog gathered to celebrate both the launch of this new partnership and Lucid Group’s twelve-year anniversary.  2019 is set to be a...

Lucid Group Communications Limited

- PMLiVE

Rare Disease Day 2019: A patient perspective on primary sclerosing cholangitis

An interview with Debbie, office manager at Porterhouse Medical, on what it’s like to live with the rare disease, PSC. Read more ...

Porterhouse Medical Group

Statistics and Infographics for Rare Disease Day

Rare Disease Day 2019

Today is #RareDiseaseDay and is an opportunity to highlight some truly unbelievable/frightening statistics around rare diseases.

Cuttsy + Cuttsy

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links